These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31136751)

  • 21. Subspecies diversity in bacteriocin production by intestinal Lactobacillus salivarius strains.
    O' Shea EF; O' Connor PM; Raftis EJ; O' Toole PW; Stanton C; Cotter PD; Ross RP; Hill C
    Gut Microbes; 2012; 3(5):468-73. PubMed ID: 22892690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gentamicin resistance in biofilm producing Pseudomonas aeruginosa causing catheter associated urinary tract infections.
    Suman E; Varghese S; Jose J
    Indian J Med Sci; 2005 May; 59(5):214-6. PubMed ID: 15985732
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa.
    Bala A; Chhibber S; Harjai K
    Int J Med Microbiol; 2014 Nov; 304(8):1199-208. PubMed ID: 25240873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens.
    Oh SH; Park HS; Kim HS; Yun JY; Oh K; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2017 Dec; 50(6):700-706. PubMed ID: 28668680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.
    Barrett E; Hayes M; O'Connor P; Gardiner G; Fitzgerald GF; Stanton C; Ross RP; Hill C
    Appl Environ Microbiol; 2007 Jun; 73(11):3719-23. PubMed ID: 17416691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of antimicrobial substance from Lactobacillus salivarius KL-D4 and its application as biopreservative for creamy filling.
    Therdtatha P; Tandumrongpong C; Pilasombut K; Matsusaki H; Keawsompong S; Nitisinprasert S
    Springerplus; 2016; 5(1):1060. PubMed ID: 27462508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
    Cernohorská L; Sláviková P
    Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):154-7. PubMed ID: 21114003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
    Seifert H; Körber-Irrgang B; Kresken M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):227-234. PubMed ID: 28705666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Zhang X; Niu S; Zhang L
    Urol Int; 2014; 93(4):464-9. PubMed ID: 24642393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections.
    Newman JW; Floyd RV; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28605563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity.
    Sabharwal N; Chhibber S; Harjai K
    Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections.
    Mittal R; Sharma S; Chhibber S; Harjai K
    J Biomed Sci; 2008 Nov; 15(6):731-41. PubMed ID: 18688758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fighting
    Varponi I; Ferro S; Menilli L; Grapputo A; Moret F; Mastrotto F; Marin O; Sandrelli F
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569868
    [No Abstract]   [Full Text] [Related]  

  • 37. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Sci Rep; 2017 Jul; 7(1):6953. PubMed ID: 28761101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
    Geng M; Austin F; Shin R; Smith L
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.
    Takeda S; Nakai T; Wakai Y; Ikeda F; Hatano K
    Antimicrob Agents Chemother; 2007 Mar; 51(3):826-30. PubMed ID: 17145788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain.
    Traub WH; Scheidhauer R; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(4):243-59. PubMed ID: 9681201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.